Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
58,224,309
-
Share change
-
+5,756,005
-
Total reported value
-
$581,745,577
-
Put/Call ratio
-
88%
-
Price per share
-
$9.99
-
Number of holders
-
149
-
Value change
-
+$42,465,959
-
Number of buys
-
69
-
Number of sells
-
84
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q4 2021
As of 31 Dec 2021,
BLUEBIRD BIO INC - COM (BLUE) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,224,309 shares.
The largest 10 holders included
STATE STREET CORP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., FIRST TRUST ADVISORS LP, BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, JPMORGAN CHASE & CO, CREDIT SUISSE AG/, and GOLDMAN SACHS GROUP INC.
This page lists
149
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.